Today's post is from Peter Essele, vice president of investment management and research.
As we turn the page on 2020 (thankfully!), market practitioners are starting to release outlook pieces and portfolio positioning recommendations for the year ahead. The recent strong performance of value, when compared with growth, has many investors wondering whether it makes sense to consider an overweight to this seemingly forgotten asset class, which has benefited greatly from the recent vaccine rally.